These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 5042921)

  • 1. The serologic behaviour of neuraminidase-treated lymphoid cells. Alloantigenicity and complement sensitivity.
    Ray PK; Gewurz H; Simmons RL
    Clin Exp Immunol; 1972 Jul; 11(3):441-60. PubMed ID: 5042921
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of neuraminidase on the stimulatory capacity of cells in human mixed lymphocyte cultures.
    Lundgren G; Simmons RL
    Clin Exp Immunol; 1971 Dec; 9(6):915-26. PubMed ID: 4110358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of neuraminidase on serological properties of murine lymphoid cells.
    Schlesinger M; Amos BD
    Transplant Proc; 1971 Mar; 3(1):895-7. PubMed ID: 4106346
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative effect of viral and bacterial neuraminidase on the complement sensitivity of lymphoid cells.
    Ray PK; Simmons RL
    Clin Exp Immunol; 1972 Jan; 10(1):139-50. PubMed ID: 4335984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of C3 receptors on lymphoid cells with different complement sources.
    Dierich MP; Pellegrino MA; Ferrone S; Reisfeld RA
    J Immunol; 1974 May; 112(5):1766-73. PubMed ID: 4522461
    [No Abstract]   [Full Text] [Related]  

  • 6. Unmasking of xenogeneic neo-antigens on mouse lymphoid cell surfaces by Vibrio cholerae neuraminidase.
    Ray PK; Simmons RL
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):217-22. PubMed ID: 4118961
    [No Abstract]   [Full Text] [Related]  

  • 7. "Unmasking" of human lymphoid cell heteroantigens by neuraminidase treatment.
    Rosenberg SA; Plocinik BA; Rogentine GN
    J Natl Cancer Inst; 1972 May; 48(5):1271-6. PubMed ID: 4624148
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific lysis of human colon tumor cells by antibodies to CEA and isoantigen A: dependence on rabbit serum or neuraminidase.
    Tompkins WA; Seth PB; Yip DM; Palmer JL; Gee SR; Rawls WE
    J Immunol; 1976 Nov; 117(5 Pt.2):1943-8. PubMed ID: 792333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytotoxic reactivity and sialic acid content of human lymphoid cells.
    Reisner EG; Flye MW; Chung KS; Amos DB
    Tissue Antigens; 1974; 4(1):7-20. PubMed ID: 4545917
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors involved in the cytotoxicity of normal guinea pig serum for cells of murine tumor TA3 sublines treated with neuraminidase.
    Hughes RC; Palmer PD; Sanford BH
    J Immunol; 1973 Oct; 111(4):1071-80. PubMed ID: 4728677
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the cytolytic action of guinea pig and rabbit complement on sensitized nucleated mouse cells.
    Koene RA; McKenzie IF
    J Immunol; 1973 Dec; 111(6):1894-901. PubMed ID: 4750871
    [No Abstract]   [Full Text] [Related]  

  • 12. Reactions of nascent C567 (reactive lysis).
    Goldman JN
    Transplant Proc; 1974 Mar; 6(1):21-5. PubMed ID: 4817055
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro methods for assessment of antibody-mediated tumor immunity.
    Levy NL; Amos DB; Solovieff GV; dos Reis AP
    Natl Cancer Inst Monogr; 1972 Dec; 35():5-11. PubMed ID: 4349154
    [No Abstract]   [Full Text] [Related]  

  • 14. The complement-binding and absorptive capacity of human white blood cells treated with neuraminidase.
    Reisner EG; Amos DB
    Transplantation; 1972 Oct; 14(4):455-61. PubMed ID: 4404957
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytolysis of neuraminidase-treated autochthonous lymphoid cells by autologous serum.
    Ray PK; Sundaram K
    Clin Exp Immunol; 1975 Mar; 19(3):529-32. PubMed ID: 1204249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of neuraminidase to unmask allogeneic antigens on cell surfaces.
    Ray PK; Simmons RL
    Proc Soc Exp Biol Med; 1971 Nov; 138(2):600-4. PubMed ID: 5118473
    [No Abstract]   [Full Text] [Related]  

  • 17. Normal human sera with cytotoxic reactivity to acute lymphocytic leukemia cells.
    Bias WB; Santos GW; Burke PJ; Mullins GM; Humphrey RL
    Transplant Proc; 1973 Mar; 5(1):949-52. PubMed ID: 4121184
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of complement in the HL-A antibody-mediated lysis of lymphocytes.
    Ferrone S; Cooper NR; Pellegrino MA; Reisfeld RA
    Transplant Proc; 1974 Mar; 6(1):13-9. PubMed ID: 4856285
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential release of sialic acid from normal and malignant cells by Vibrio cholerae neuraminidase or influenza virus neuraminidase.
    Ray RK; Simmons RL
    Cancer Res; 1973 May; 33(5):936-9. PubMed ID: 4703124
    [No Abstract]   [Full Text] [Related]  

  • 20. Relation of the neuraminidase-revealed antigens of human lymphocytes and erythrocytes.
    Reisner EG
    Transplantation; 1975 Apr; 19(4):357-60. PubMed ID: 1171544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.